fda declares semaglutide shortage over Over? The FDA's Controversial Claim Shakes GLP-1 Users FDA declares semaglutide shortage over
Description
Researchers point out that neither of those estimates accounts for the costs of the medications, since that has been uncertain and subject to change
[Google Scholar] 184.Lupien SJ, Leon Mde, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ
Cost is another consideration when deciding whether Semaglutide is worth it for weight loss
Mounjaro: GoodRx notes list price about $1,080 per fill and many consumers pay $1,000-$1,200+ monthly without insurance
Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a 39-amino acid dual agonist targeting both GLP-1 and GIP receptors, also incorporating a fatty acid modification for half-life extension, and is the most commercially significant synthetic peptide ever produced at scale
No insurance hassles, no waiting rooms
